Literature DB >> 18582494

Suppression of glucocorticoid secretion induces a behaviorally depressive state in rotarod performance in rat.

Kazushige Mizoguchi1, Ryuji Ikeda, Hirotaka Shoji, Yayoi Tanaka, Takeshi Tabira.   

Abstract

Glucocorticoid hormones are important in the maintenance of many brain functions, and their receptors distribute abundantly throughout the brain. In patients with several neuropsychiatric disorders such as depression, dysregulation of the glucocorticoid negative feedback system is the consistent observations, which is thought to be caused by reduced glucocorticoid response at the several feedback sites including the brain. In the present study, we examined whether reduced glucocorticoid actions via suppression of circulating glucocorticoids by adrenalectomy (ADX) induced a behavioral depressive state using the rotarod test. We found that ADX impaired the rotarod performance while it did not affect the traction performance and locomotor activity. Moreover, this impairment was significantly reversed by corticosterone replacement treatment and was ameliorated by the infusion of D1 receptor agonist SKF 81297 into the prefrontal cortex (PFC) in a dose-dependent manner. Considering the previous findings that ADX reduces dopaminergic transmission in the PFC, the present results suggest that suppression of circulating glucocorticoids induces a behaviorally depressive state that is caused by a D1 receptor-mediated hypodopaminergic mechanism in the PFC. This finding would help to understand the involvement of the dysregulated feedback system in the pathogenesis of depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582494     DOI: 10.1016/j.pbb.2008.05.021

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  A new strategy for antidepressant prescription.

Authors:  Francis Lavergne; Thérèse M Jay
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

2.  Incentive processing in Congenital Adrenal Hyperplasia (CAH): a reward-based antisaccade study.

Authors:  Sven C Mueller; Teresa Daniele; Jessica MacIntyre; Katherine Korelitz; Christina Carlisi; Michael G Hardin; Carol Van Ryzin; Deborah P Merke; Monique Ernst
Journal:  Psychoneuroendocrinology       Date:  2012-08-21       Impact factor: 4.905

3.  Neuroprotective effects of the immunomodulatory drug Setarud on cerebral ischemia in male rats.

Authors:  Farzaneh Vafaee; Nasser Zangiabadi; Fatemeh Mehdi Pour; Farzaneh Dehghanian; Majid Asadi-Shekaari; Hossein Karimi Afshar
Journal:  Neural Regen Res       Date:  2012-09-25       Impact factor: 5.135

Review 4.  Enduring, Sexually Dimorphic Impact of In Utero Exposure to Elevated Levels of Glucocorticoids on Midbrain Dopaminergic Populations.

Authors:  Glenda E Gillies; Kanwar Virdee; Ilse Pienaar; Felwah Al-Zaid; Jeffrey W Dalley
Journal:  Brain Sci       Date:  2016-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.